Mycopathologia

, Volume 183, Issue 3, pp 619–622 | Cite as

Liposomal Amphotericin B as Monotherapy in Relapsed Coccidioidal Meningitis

  • Ethan R. Stewart
  • Matthew L. Eldridge
  • Ian McHardy
  • Stuart H. Cohen
  • George R. ThompsonIII
Short Communication
  • 81 Downloads

Abstract

Coccidioidal meningitis remains a difficult clinical problem, and despite life-long therapy with triazole antifungals, relapses of disease and medication intolerance occur necessitating salvage treatment. We report two patients with recurrent coccidioidal meningitis who improved following a 2-week course of liposomal amphotericin B monotherapy and discuss potential advantages of this treatment option.

Keywords

Coccidioides Coccidioidomycosis Liposomal amphotericin B Meningitis Relapse 

Notes

Funding

Departmental funds were used for this project.

Compliance with Ethical Standards

Conflict of interest

None.

References

  1. 1.
    Galgiani JN, Ampel NM, Blair JE, Catanzaro A, Geertsma F, Hoover SE, et al. 2016 infectious diseases society of America (IDSA) clinical practice guideline for the treatment of coccidioidomycosis. Clin Infect Dis. 2016;63(6):e112–46.CrossRefPubMedGoogle Scholar
  2. 2.
    Galgiani JN, Catanzaro A, Cloud GA, Johnson RH, Williams PL, Mirels LF, et al. Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis. A randomized, double-blind trial. Mycoses Study Group. Ann Intern Med. 2000;133(9):676–86.CrossRefPubMedGoogle Scholar
  3. 3.
    Stevens DA, Rendon A, Gaona-Flores V, Catanzaro A, Anstead GM, Pedicone L, et al. Posaconazole therapy for chronic refractory coccidioidomycosis. Chest. 2007;132(3):952–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Stevens DA, Shatsky SA. Intrathecal amphotericin in the management of coccidioidal meningitis. Semin Respir Infect. 2001;16(4):263–9.CrossRefPubMedGoogle Scholar
  5. 5.
    Thompson GR 3rd. Pulmonary coccidioidomycosis. Semin Respir Criti Care Med. 2011;32(6):754–63.CrossRefGoogle Scholar
  6. 6.
    Hodge G, Cohen SH, Thompson GR 3rd. In vitro interactions between amphotericin B and hydrocortisone: potential implications for intrathecal therapy. Med Mycol. 2015;53(7):749–53.CrossRefPubMedGoogle Scholar
  7. 7.
    Graybill JR, Bocanegra R. Liposomal amphotericin B therapy of murine histoplasmosis. Antimicrob Agents Chemother. 1995;39(8):1885–7.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Hiemenz JW, Walsh TJ. Lipid formulations of amphotericin B: recent progress and future directions. Clin Infect Dis. 1996;22(Suppl 2):S133–44.CrossRefPubMedGoogle Scholar
  9. 9.
    Hamill RJ, Sobel JD, El-Sadr W, Johnson PC, Graybill JR, Javaly K, et al. Comparison of 2 doses of liposomal amphotericin B and conventional amphotericin B deoxycholate for treatment of AIDS-associated acute cryptococcal meningitis: a randomized, double-blind clinical trial of efficacy and safety. Clin Infect Dis. 2010;51(2):225–32.CrossRefPubMedGoogle Scholar
  10. 10.
    Johnson PC, Wheat LJ, Cloud GA, Goldman M, Lancaster D, Bamberger DM, et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann Intern Med. 2002;137(2):105–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Clemons KV, Sobel RA, Williams PL, Pappagianis D, Stevens DA. Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidioidal meningitis in rabbits. Antimicrob Agents Chemother. 2002;46(8):2420–6.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Galgiani JN, Catanzaro A, Cloud GA, Higgs J, Friedman BA, Larsen RA, et al. Fluconazole therapy for coccidioidal meningitis. The NIAID-Mycoses Study Group. Ann Intern Med. 1993;119(1):28–35.CrossRefPubMedGoogle Scholar
  13. 13.
    Clemons KV, Capilla J, Sobel RA, Martinez M, Tong AJ, Stevens DA. Comparative efficacies of lipid-complexed amphotericin B and liposomal amphotericin B against coccidioidal meningitis in rabbits. Antimicrob Agents Chemother. 2009;53(5):1858–62.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media B.V., part of Springer Nature 2018

Authors and Affiliations

  • Ethan R. Stewart
    • 1
  • Matthew L. Eldridge
    • 1
  • Ian McHardy
    • 2
  • Stuart H. Cohen
    • 1
  • George R. ThompsonIII
    • 1
    • 2
  1. 1.Department of Internal Medicine, Division of Infectious DiseasesUniversity of California Davis Medical CenterSacramentoUSA
  2. 2.Department of Medical Microbiology and Immunology, Department of Medicine, Division of Infectious DiseasesUniversity of California – DavisDavisUSA

Personalised recommendations